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Abstract
We describe a case of duodenal gangliocytic paraganglioma showing lymph node metastasis. A 61-year-old Japanese 
man underwent pylorus preserving pancreaticoduodenectomy to remove a tumor at the papilla of Vater. The section 
of the tumor extending from the mucosa to submucosa of the duodenum was sharply demarcated, solid, and white-
yellowish. Neither necrosis nor hemorrhage was present. Histological examination confirmed the 
immunohistochemical identification of three components comprising epithelioid cells, spindle-shaped cells, and 
ganglion-like cells. Epithelioid cells showed positive reactivity for synaptophysin, somatostatin, and CD56. In contrast, 
spindle-shaped cells showed positive reactivity for S-100 protein, but not for synaptophysin, somatostatin or CD56. 
Furthermore, we found lymph node metastasis despite lack of bcl-2 and p53 expression. In addition to the rarity of the 
tumor, we are describing here the present case suggests the malignant potency of the tumor despite lack of 
acceptable prognostic indicators for neuroendocrine tumor.
Background
Gangliocytic paraganglioma is a rare neuroendocrine
tumor that usually occurs at the second portion of the
duodenum, and its ultimate diagnosis requires a histo-
pathological identification of three identical components
comprising epithelioid cells, spindle-shaped cells, and
ganglion-like cells [1]. This tumor has been regarded as
benign in general, but a few cases with lymph node
metastasis have been reported which required extensive
surgical removal [Table 1]. In addition to the rarity of the
tumor, the present case suggests the malignant potency of
the tumor despite lack of bcl-2 and p53 expression, which
has been known as a marker for malignancy of neuroen-
docrine tumors [2-5].
Case presentation
A 61-year-old Japanese man presented with epigastralgia
and tarry stool a month before admission. He had history
of neither habitual smoking nor irradiation. A gastroin-
testinal endoscopy revealed a tumor with central ulcer-
ation at the papilla of Vater. He was referred to our
hospital after an endoscopic procedure for the bleeding.
Subsequent examinations in our hospital included upper
gastrointestinal endoscopy, magnetic resonance cholang-
iopancreatography, endoscopic retrograde cholangiopan-
creatography, and endoscopic ultrasonography, which led
to the detection of a tumor at the papilla of Vater that
suggested regional lymph node metastasis. A biopsy
before the operation suggested a duodenal carcinoid fol-
lowing histological findings and the results of immuno-
histochemical examination. The tumor cells showed
positive reactivity for synaptophysin, somatostatin, and
CD56. The patient underwent pylorus preserving pancre-
aticoduodenectomy with lymph nodes dissection.
Pathological findings
The surgical specimen, an en-bloc comprising duode-
num, bile duct, gallbladder, and head of pancreas, was
fixed with 10% buffered formalin. A solid tumor 25 × 30 ×
25 mm in size was found at the papilla of Vater whose
surface was lobulated and covered by attenuated mucosa
showing ulcer formation at the center of elevation (Fig.
1A). The section of the tumor extending from the mucosa
to submucosa of the duodenum was sharply demarcated,
solid and white-yellowish (Fig. 1B). Neither necrosis nor
hemorrhage was present. Sections of paraffin-embedded
tissue were prepared and stained with hematoxylin and
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eosin (HE) double stain for light microscopic observa-
tion. Histological examination showed that a large body
of the tumor was present in the submucosa and invaded a
part of the muscularis propria, but the bile duct and pan-
creas were not involved. Histological observation also
revealed that the tumor consisted of three identical cellu-
lar components: epithelioid cells, spindle-shaped cells,
and ganglion-like cells. Tumor cells of an epithelioid cell
type usually nested and had a round to oval-shaped
nucleus with an inconspicuous nucleolus, as well as a
clear and eosinophilic cytoplasm (Fig. 2A). Tumor cells of
a spindle-shaped cell type encompassed the nests of epi-
thelioid cells with alignment of a single cell layer and had
an elongated and plump nucleus, including an attenuated
eosinophilic cytoplasm (Fig. 2A). Tumor cells of a gan-
g l i o n - l i k e  c e l l  t y p e  w e r e  r a r e l y  s e e n  a n d  h a d  a  r o u n d
nucleus with conspicuous nucleolus, as well as a polyhe-
dral amphophilic cytoplasm (Fig. 2B). In addition to the
absence of mitosis among these cells, neither necrosis nor
hemorrhage was found. However, tumor cells of an epi-
thelioid cell type showed regional lymph node metastasis
(Fig. 2C and 2D).
Immunohistochemical findings
Several kinds of antibodies were used to evaluate and
identify tumor cells immunohistochemically. Tumor cells
of both epithelioid and ganglion-like cell types showed
positive reactivity for synaptophysin, somatostatin, and
CD56 (Fig. 3A, B, and 3C). In contrast, the spindle-
shaped cell type showed positive reactivity for S-100 pro-
tein (Fig. 3D), but not for synaptophysin, somatostatin or
CD56. Neither cell type was positive for chromogranin A
(Fig. 3E), cytokeratin AE1/AE3 or epithelial membrane
antigen (EMA). MIB-1 (Ki-67) labeling index estimated
less than 1% in both primary and metastatic foci. Tumor
cells invade into the lymphatic lumen which can be rec-
ognized by an enclose of podoplanin (D2-40)-positive
endothelial cell (Fig. 3F). Tumor cells of the epithelioid
cell type metastasizing at the lymph node showed posi-
tive reactivity for synaptophysin (Fig. 3G). No tumor cells
of the spindle-shaped cell type were found in the meta-
static focus as confirmed by the lack of S-100 protein-
positive cells (Fig. 3H). Furthermore, tumor cells of the
epithelioid cell type in both primary and metastatic foci
showed negative reactivity for both bcl-2 and p53 in the
present case (Fig. 4A, B, C, and 4D).
Table 1: Gangliocytic paraganglioma showing lymph node metastasis
Reference Year Age 
(years)
Sex Chief Clinical 
presentation
Site Size 
(mm)
Operation Follow up 
(months)
Inai et al. [16] 1989 17 Male Hematoemesis Papilla of 
Vater
20 PD NED 32
Hashimoto et al. [17] 1992 47 Male Incidental 
findings
Papilla of 
Vater
65 PD NED 14
Takabayashi et al. [18] 1993 63 Female Abdominal pain Papilla of 
Vater
32 PPPD NED 24
Tomic et al. [19] 1996 74 Female Abdominal pain, 
vomiting, weight 
loss
Pancreas 40 PD NED 19
Sundararajan et al. [1] 2003 67 Female Incidental 
findings
Second part 
of duodenum
50 PD NED 9
Bucher et al. [20] 2004 31 Female Anemia, 
subclinical 
jaundice
Papilla of 
Vater
30 PPPD NED 44
Wong et al. [10] 2005 49 Female Melena Duodenum 14 PPPD NED 12
Witkiewicz et al. [21] 2007 38 Female Abdominal pain Papilla of 
Vater
15 PPPD NR
Mann et al. [22] 2009 17 Female Abdominal pain, 
vomiting, weight 
loss
Duodenum NR PPPD NR
Present case 2010 61 Male Epigastralgia, 
tarry stool
Papilla of 
Vater
30 PPPD NED 6
NR: not reported, PD: pancreatoduodenectomy, PPPD: pylorus-preserving pancreaticoduodenectomy
NED: no evidence of disease
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Discussion
Gangliocytic paraganglioma has been known as a rare
and benign neuroendocrine tumor. This condition occurs
at the gastrointestinal tract, especially at the second por-
tion of the duodenum [1]. Major clinical symptoms of the
disease include abdominal pain, nausea, vomiting, and
gastrointestinal bleeding. Biliary obstruction has rarely
been reported as a devastating complication [6,7]. Histo-
pathological diagnosis of the disease should require a
confirmation of three identical components comprising
epithelioid cells, spindle-shaped cells, and ganglion-like
cells [1,6-8]. Carcinoid tumor, paraganglioma, ganglion-
euroma or spindle cell tumors (including nerve sheath
tumors, smooth muscle tumors and gastrointestinal
stromal tumors) should be referred as diseases for differ-
ential diagnosis in cases of histopathological investigation
[6]. To identify the three cellular components, in addition
to the detailed microscopic examination of hematoxylin
and eosin double stained sections, phenotypical expres-
sion analysis by immunohistochemical examination has
been regarded as an important diagnostic clue [8,9].
Although gangliocytic paraganglioma has been regarded
as a benign tumor, we found nine cases showing lymph
node metastasis among the literature [Table 1]. The table
surmises major clinical data of ten cases of gangliocytic
paraganglioma with lymph node metastasis including the
present case were analyzed. Patient age ranged from 17 to
74 (mean: 46.4). Male-to-female ratio was 3:7. Tumor
sizes ranged from 14 to 65 mm (mean: 32.9). Nine cases
occurred at duodenum, but one occurred at pancreas.
Although present patient was older, its location and size
follows characteristic manner of the disease. One case
had irradiation as an adjuvant therapy [10], no recurrence
or distant metastasis, however, was described in all
patients who we had extracted from the previously
reported cases. Therefore, we decided to avoid any adju-
vant therapy from the present case. The results of immu-
nohistochemical examinations are summarized in Table 2
with those of previously reported cases of gangliocytic
paraganglioma with lymph node metastasis. In the pres-
ent case, three identical components were clearly identi-
fied by phenotypical expression analysis, which
correspond to those previously reported with the excep-
tion of positive reactivity for chromogranin A. In addi-
tion, the present case also showed lymphatic involvement
of tumor cells of an epithelioid cell type at the primary
focus and regional lymph node metastasis. Furthermore,
there was a study suggesting approximately 5% of gangli-
ocytic paraganglioma demonstrate malignant behavior
[10], an importance of imaging examinations before an
operation should be emphasize to determine the most
suitable method of surgical intervention [11]. On the
other hand, several studies conducting to neuroendo-
crine tumor have reported that bcl-2 and/or p53 expres-
sion might be correlated with malignant behavior of them
[2-5], whereas no studies were found of which investiga-
tion was limited in gangliocytic paraganglioma.
T h e r e f o r e ,  w e  u n f o r t u n a t e l y  h a v e  t o  c o n c l u d e  a n
immunohistochemical evaluation using bcl-2 or p53 in
gangliocytic paraganglioma has a limited prognostic
value mostly due to its rarity. In fact, some studies indi-
Figure 1 The surgical specimen. (A) A solid tumor measuring 25 × 30 
× 25 mm in size was found at the papilla of Vater which was lobulated 
and covered by attenuated mucosa with ulcer formation at the center 
of elevation. (B) The section of the tumor extending from the mucosa 
to submucosa of the duodenum was sharply demarcated, solid, and 
white-yellowish.
Figure 2 Photomicrographs showing different types of tumor 
cells. (A) Tumor cells of epithelioid cell type are usually nested which 
are encompassed by those of spindle-shaped cell type with alignment 
of a single cell layer (HE double stain, × 400). (B) Ganglion-like cells; 
third type of the tumor cell had a large and oval nucleus with conspic-
uous nucleolus, as well as a polyhedral amphophilic cytoplasm (HE 
double stain, × 1000). (C and D) The metastasizing component of the 
tumor at the lymph node comprised the epithelioid cell type alone (HE 
double stain, × 100, × 400, respectively).Okubo et al. Diagnostic Pathology 2010, 5:27
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cated that bcl-2 and/or p53 expression was not correlated
with malignant behavior in gastrointestinal neuroendo-
crine tumors [12,13]. In addition, MIB-1 (Ki-67) has been
known as a prognostic indicator in neuroendocrine
tumor [14]. However, none of previously reported cases
of gangliocytic paraganglioma with lymph node metasta-
sis described the MIB-1 (Ki-67) labeling index and that of
the present case estimated less than 1% in both primary
and metastatic foci. These finding suggests that immuno-
histochemical evaluation using MIB-1 (Ki-67) has also a
limited prognostic value in gangliocytic paraganglioma.
In the meantime, Hagemeyer et al. reported the case of
pulmonary paraganglioma with p53 expression after
Tschernobyl radiation [15]. They suggested that the irra-
diation had little influence on development of pulmonary
paraganglioma, but smoking or irradiation could be asso-
ciated with p53 expression. A part of their notion may be
supported because our patient showed no p53 expression
who had history of neither smoking nor irradiation. How-
ever, it should be unripe that smoking or irradiation has a
relationship to p53 expression of tumor cell in ganglio-
cytic paraganglioma. We wish to emphasize the impor-
tance of imaging examinations to monitor for recurrence
or metastasis after the operation, because appropriate
prognostic indicators have not been accepted using
immunohistochemical evaluation.
The operation of our patient resulted in success, and he
still maintains a high quality of life six months after that.
Neither chemotherapy nor radiation has started because
consensus on the adjuvant therapy for this tumor has not
been reached at present.
Conclusions
W e  d e s c r i b e  a  c a s e  o f  d u o d e n a l  g a n g l i o c y t i c  p a r a g a n -
glioma showing lymph node metastasis, of which histo-
logical and immunohistochemical examinations revealed
the tumor comprised three identical cellular components;
epithelioid cells, spindle-shaped cells, and ganglion-like
c e l l s .  F u r t h e r m o r e ,  t h e  c a s e  s h o w e d  n o d e  m e t a s t a s i s
despite lack of bcl-2 and p53 expression.
In addition to the rarity of the tumor, we wish to
emphasize that the malignant potency of the tumor
Figure 3 Photomicrographs showing representative immunohistochemistry. (A, B, and C) Epithelioid cells showed positive reactivity for synap-
tophysin, somatostatin, and CD56 (× 400). (D) Spindle-shaped cells showed positive reactivity for S-100 protein (× 400). (E) Tumor cells of both types 
showed negative reactivity for chromogranin A (× 400). (F) Tumor cells invade into the lymphatic lumen (immunohistochemistry with podoplanin 
(D2-40) antibody, × 400). (G) Epithelioid cells metastasizing at the lymph node showed positive reactivity for synaptophysin (× 400). (H) No spindle-
shaped cells were found in the metastatic focus as confirmed by the lack of S-100 protein-positive cells (× 400).
Figure 4 Photomicrographs showing immunohistochemistry for 
bcl-2 and p53. (A and B) Tumor cells in primary focus showed negative 
reactivity for both bcl-2 and p53 (× 400). (C and D) Tumor cells in met-
astatic focus showed negative reactivity for both bcl-2 and p53 (× 400).Okubo et al. Diagnostic Pathology 2010, 5:27
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despite lack of acceptable prognostic indicators for neu-
roendocrine tumor.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for
review by the Editor-in-Chief of this journal.
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